Investment eyes 'middle class' African pharma demand
Changing disease patterns, urbanisation, industry consolidation and policy shifts shape the pharma sector's outlook
You must be signed in to read this analysis
In this article
- Maturing markets
- East Africa
- Southern Africa
- Driving demand
- Changing challenge
- Urbanisation
- Asia ascending
- Locals lose out
- Regulatory reforms
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
_350.jpg "An employee inspects medication tablets produced at Azal Pharmaceutical Industries in Khartoum, Sudan (Reuters/Mohamed Nureldin Abdallah)")